These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24128777)

  • 1. What has been the effect on trial outcome assessments of a decade of patient participation in OMERACT?
    de Wit MP; Abma TA; Koelewijn-van Loon MS; Collins S; Kirwan J
    J Rheumatol; 2014 Jan; 41(1):177-84. PubMed ID: 24128777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitating and inhibiting factors for long-term involvement of patients at outcome conferences--lessons learnt from a decade of collaboration in OMERACT: a qualitative study.
    de Wit M; Abma T; Koelewijn-Van Loon M; Collins S; Kirwan J
    BMJ Open; 2013 Aug; 3(8):e003311. PubMed ID: 23975104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involving patient research partners has a significant impact on outcomes research: a responsive evaluation of the international OMERACT conferences.
    de Wit M; Abma T; Koelewijn-van Loon M; Collins S; Kirwan J
    BMJ Open; 2013 May; 3(5):. PubMed ID: 23667160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Stepwise Development of Patient Research Partnership: 14 Years' Experience of Actions and Consequences in Outcome Measures in Rheumatology (OMERACT).
    de Wit M; Kirwan JR; Tugwell P; Beaton D; Boers M; Brooks P; Collins S; Conaghan PG; D'Agostino MA; Hofstetter C; Hughes R; Leong A; Lyddiatt A; March L; May J; Montie P; Richards P; Simon LS; Singh JA; Strand V; Voshaar M; Bingham CO; Gossec L
    Patient; 2017 Apr; 10(2):141-152. PubMed ID: 27704486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "If i wasn't this robust": patients' expectations and experiences at the Outcome Measures in Rheumatology Conference 2010.
    de Wit MP; Koelewijn-van Loon MS; Collins S; Abma TA; Kirwan J
    Patient; 2013; 6(3):179-87. PubMed ID: 23736943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for the Involvement of Patient Research Partners (PRP) in OMERACT Working Groups. A Report from the OMERACT 2014 Working Group on PRP.
    Cheung PP; de Wit M; Bingham CO; Kirwan JR; Leong A; March LM; Montie P; Scholte-Voshaar M; Gossec L
    J Rheumatol; 2016 Jan; 43(1):187-93. PubMed ID: 25877496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol.
    Kelly A; Tong A; Tymms K; March L; Craig JC; De Vera M; Evans V; Hassett G; Toupin-April K; van den Bemt B; Teixeira-Pinto A; Alten R; Bartlett SJ; Campbell W; Dawson T; Gill M; Hebing R; Meara A; Nieuwlaat R; Shaw Y; Singh JA; Suarez-Almazor M; Sumpton D; Wong P; Christensen R; Beaton D; de Wit M; Tugwell P;
    Trials; 2018 Mar; 19(1):204. PubMed ID: 29587864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group.
    Klokker L; Tugwell P; Furst DE; Devoe D; Williamson P; Terwee CB; Suarez-Almazor ME; Strand V; Woodworth T; Leong AL; Goel N; Boers M; Brooks PM; Simon LS; Christensen R
    J Rheumatol; 2017 Dec; 44(12):1916-1919. PubMed ID: 27744393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can we decide which outcomes should be measured in every clinical trial? A scoping review of the existing conceptual frameworks and processes to develop core outcome sets.
    Idzerda L; Rader T; Tugwell P; Boers M
    J Rheumatol; 2014 May; 41(5):986-93. PubMed ID: 24584917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0.
    Boers M; Kirwan JR; Wells G; Beaton D; Gossec L; d'Agostino MA; Conaghan PG; Bingham CO; Brooks P; Landewé R; March L; Simon LS; Singh JA; Strand V; Tugwell P
    J Clin Epidemiol; 2014 Jul; 67(7):745-53. PubMed ID: 24582946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes from the Patient Perspective Workshop at OMERACT 6.
    Kirwan J; Heiberg T; Hewlett S; Hughes R; Kvien T; Ahlmèn M; Boers M; Minnock P; Saag K; Shea B; Suarez Almazor M; Taal E
    J Rheumatol; 2003 Apr; 30(4):868-72. PubMed ID: 12672218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0.
    Boers M; Kirwan JR; Gossec L; Conaghan PG; D'Agostino MA; Bingham CO; Brooks PM; Landewé R; March L; Simon L; Singh JA; Strand V; Wells GA; Tugwell P
    J Rheumatol; 2014 May; 41(5):1025-30. PubMed ID: 24584913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Worker productivity outcome measures: OMERACT filter evidence and agenda for future research.
    Tang K; Boonen A; Verstappen SM; Escorpizo R; Luime JJ; Lacaille D; Fautrel B; Bosworth A; Cifaldi M; Gignac MA; Hofstetter C; Leong A; Montie P; Petersson IF; Purcaru O; Bombardier C; Tugwell PS; Beaton DE
    J Rheumatol; 2014 Jan; 41(1):165-76. PubMed ID: 24128774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument Sets.
    Tunis SR; Maxwell LJ; Graham ID; Shea BJ; Beaton DE; Bingham CO; Brooks P; Conaghan PG; D'Agostino MA; de Wit MP; Gossec L; March LM; Simon LS; Singh JA; Strand V; Wells GA; Tugwell P
    J Rheumatol; 2017 Oct; 44(10):1551-1559. PubMed ID: 28765256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The OMERACT filter for Outcome Measures in Rheumatology.
    Boers M; Brooks P; Strand CV; Tugwell P
    J Rheumatol; 1998 Feb; 25(2):198-9. PubMed ID: 9489805
    [No Abstract]   [Full Text] [Related]  

  • 16. Patient perspective on outcomes in rheumatology -- a position paper for OMERACT 9.
    Kirwan JR; Newman S; Tugwell PS; Wells GA
    J Rheumatol; 2009 Sep; 36(9):2067-70. PubMed ID: 19738215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibromyalgia syndrome.
    Mease P; Arnold LM; Bennett R; Boonen A; Buskila D; Carville S; Chappell A; Choy E; Clauw D; Dadabhoy D; Gendreau M; Goldenberg D; Littlejohn G; Martin S; Perera P; Russell IJ; Simon L; Spaeth M; Williams D; Crofford L
    J Rheumatol; 2007 Jun; 34(6):1415-25. PubMed ID: 17552068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward a generalized framework of core measurement areas in clinical trials: a position paper for OMERACT 11.
    Boers M; Idzerda L; Kirwan JR; Beaton D; Escorpizo R; Boonen A; Magasi S; Sinha I; Stucki G; Tugwell P
    J Rheumatol; 2014 May; 41(5):978-85. PubMed ID: 24584922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Draft Core Set of Domains for Measuring Shared Decision Making in Osteoarthritis: An OMERACT Working Group on Shared Decision Making.
    Toupin-April K; Barton J; Fraenkel L; Li L; Grandpierre V; Guillemin F; Rader T; Stacey D; Légaré F; Jull J; Petkovic J; Scholte-Voshaar M; Welch V; Lyddiatt A; Hofstetter C; De Wit M; March L; Meade T; Christensen R; Gaujoux-Viala C; Suarez-Almazor ME; Boonen A; Pohl C; Martin R; Tugwell PS
    J Rheumatol; 2015 Dec; 42(12):2442-7. PubMed ID: 25877502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The OMERACT First-time Participant Program: Fresh Eye from the New Guys.
    Sloan VS; Grosskleg S; Pohl C; Wells GA; Singh JA
    J Rheumatol; 2017 Oct; 44(10):1560-1563. PubMed ID: 28507185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.